متابعة
Tom Metz
Tom Metz
بريد إلكتروني تم التحقق منه على pnnl.gov
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking
M Wang, JJ Carver, VV Phelan, LM Sanchez, N Garg, Y Peng, ...
Nature biotechnology 34 (8), 828-837, 2016
37702016
Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice
G Sharon, NJ Cruz, DW Kang, MJ Gandal, B Wang, YM Kim, EM Zink, ...
Cell 177 (6), 1600-1618. e17, 2019
10382019
A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease
Q Zhang, JM Ames, RD Smith, JW Baynes, TO Metz
Journal of proteome research 8 (2), 754-769, 2009
5132009
Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics
DL Diamond, AJ Syder, JM Jacobs, CM Sorensen, KA Walters, SC Proll, ...
PLoS pathogens 6 (1), e1000719, 2010
4612010
Dengue virus infection perturbs lipid homeostasis in infected mosquito cells
R Perera, C Riley, G Isaac, AS Hopf-Jannasch, RJ Moore, KW Weitz, ...
PLoS pathogens 8 (3), e1002584, 2012
3732012
Effect of genetic diagnosis on patients with previously undiagnosed disease
K Splinter, DR Adams, CA Bacino, HJ Bellen, JA Bernstein, ...
New England Journal of Medicine 379 (22), 2131-2139, 2018
3662018
Review, evaluation, and discussion of the challenges of missing value imputation for mass spectrometry-based label-free global proteomics
BJM Webb-Robertson, HK Wiberg, MM Matzke, JN Brown, J Wang, ...
Journal of proteome research 14 (5), 1993-2001, 2015
3132015
Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000− 1500 and capabilities in proteomics and metabolomics
Y Shen, R Zhang, RJ Moore, J Kim, TO Metz, KK Hixson, R Zhao, ...
Analytical chemistry 77 (10), 3090-3100, 2005
2962005
Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications
R Nagai, DB Murray, TO Metz, JW Baynes
Diabetes 61 (3), 549-559, 2012
2902012
A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation
PA Voziyan, TO Metz, JW Baynes, BG Hudson
Journal of Biological Chemistry 277 (5), 3397-3403, 2002
2772002
Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury
LE Gralinski, A Bankhead III, S Jeng, VD Menachery, S Proll, SE Belisle, ...
MBio 4 (4), 10.1128/mbio. 00271-13, 2013
2762013
Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses
VD Menachery, AJ Eisfeld, A Schäfer, L Josset, AC Sims, S Proll, S Fan, ...
MBio 5 (3), 10.1128/mbio. 01174-14, 2014
2752014
Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications
TO Metz, NL Alderson, SR Thorpe, JW Baynes
Archives of biochemistry and biophysics 419 (1), 41-49, 2003
2672003
Uncovering biologically significant lipid isomers with liquid chromatography, ion mobility spectrometry and mass spectrometry
JE Kyle, X Zhang, KK Weitz, ME Monroe, YM Ibrahim, RJ Moore, J Cha, ...
Analyst 141 (5), 1649-1659, 2016
2622016
MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
VD Menachery, A Schäfer, KE Burnum-Johnson, HD Mitchell, AJ Eisfeld, ...
Proceedings of the National Academy of Sciences 115 (5), E1012-E1021, 2018
2212018
MPLEx: a robust and universal protocol for single-sample integrative proteomic, metabolomic, and lipidomic analyses
ES Nakayasu, CD Nicora, AC Sims, KE Burnum-Johnson, YM Kim, ...
MSystems 1 (3), 10.1128/msystems. 00043-16, 2016
206*2016
A statistical framework for protein quantitation in bottom-up MS-based proteomics
Y Karpievitch, J Stanley, T Taverner, J Huang, JN Adkins, C Ansong, ...
Bioinformatics 25 (16), 2028-2034, 2009
1982009
MARRVEL: integration of human and model organism genetic resources to facilitate functional annotation of the human genome
J Wang, R Al-Ouran, Y Hu, SY Kim, YW Wan, MF Wangler, S Yamamoto, ...
The American Journal of Human Genetics 100 (6), 843-853, 2017
1942017
Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation
ES Nakayasu, M Gritsenko, PD Piehowski, Y Gao, DJ Orton, ...
Nature Protocols 16 (8), 3737-3760, 2021
1932021
Model‐driven multi‐omic data analysis elucidates metabolic immunomodulators of macrophage activation
A Bordbar, ML Mo, ES Nakayasu, AC Schrimpe‐Rutledge, YM Kim, ...
Molecular systems biology 8 (1), 558, 2012
1882012
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20